Xiyang Tang’s research shows that IGSF11 and Vista are a pair of immune checkpoints, which act on tumor proliferation and immune regulation, and have great potential as new tumor immunotherapy targets and biomarkers. The gene discussed is VSIR; the disease is neoplasm.